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showed that the prevalence of HCV infection in Kerman is
more than other provinces of Iran.
Conclusion: In contrast with other studies HBV-DNA in
these patients could not be detected, hence, it seems that228 14
iral load >104 copies/ml, 3 of them were simultaneously
BeAg positive.
Conclusion: The prevalence of HBV infection in pregnant
omen in eastern Slovakia exceeds the overall estimated
lovak prevalence, and in districts with higher Roma popula-
ion conﬁrms presumed higher prevalence of HBV infection
n this population. Majority of infected women are HBsAg
arriers, but we have conﬁrmed several cases of pregnant
omen with high viral load and increased risk of vertical
ransmission. We consider evaluation of ALT in pregnancy as
nsufﬁcient for ruling out chronic hepatitis B. This study was
upported by VEGA grant No.1/0050/08.
oi:10.1016/j.ijid.2010.02.1994
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ew approaches in in-vitro diagnosis of Hepatitis C infec-
ions: The diagnostic performance of new hepatitis C virus
ore antigen detection test
. Kocazeybek1, P. Yuksel1,∗, S. Saribas1, R. Caliskan1, S.
rgin1, M. Aslan1, A. Yalcıner2, M.M. Torun1
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Duzen Laboratory, Istanbul, Turkey
Background: There are problems currently in the diag-
osis of hepatitis C infections We aimed to investigate the
iagnostic performance of new HCV Ag (Abbott Diagnostic,
ermany.
Methods: All of the study cases were applied to the
stanbul University Microbiology and Clinical Microbiology
epartment and to the Düzen laboratory between February
008-March 2009. Molecular (real-time PCR) and serological
ethods (Micro-ELISA) were applied to the all of the cases,
23 HCV RNA-positive and anti-HCV positive cases, 48 HCV
NA negative and anti-HCV negative cases were included
s the study and negative control groups, respectively. We
valuated sensitivity, speciﬁcity, positive predictive (PPV)
nd negative predictive (NPV) values, accuracy and kappa
alues of antigen detection HCV Ag kit which includes mon-
clonal anti-HCV antibodies against HCV core antigen coated
n the solid phase.
Results: Sensitivity, speciﬁcity, PPV, NPV, accuracy and
appa values were evaluated as 94.3%, 97.9%, 99.1%, 87%,
5.3% and 88%, respectively for HCV Ag kit.
Viral load distrubition and HCV Core Ag results of HCV
NA Positive Patients
CV RNA (IU/ml) HCV RNA Positive Patients
—1000 4
001—2000 2
001—10000 2
0001—100000 13
00001 and upper 102
otal 123Conclusion: As a result, the diagnostic performance
arameters of recently developed HCVAg kit have not satis-
actory results because false negative ratio was 5% and NPV
as 87%. We suggest that this situation is related with unsuf-ternational Congress on Infectious Diseases (ICID) Abstracts
cient analytic sensitivity especially for HCV cases which
ave a 2000 IU/ml and below viral load. We suggest that the
e-evaluation of the sensitivity of this kit will be usefull for
lood screening.
oi:10.1016/j.ijid.2010.02.1995
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o detected hepatitis B virus-DNA in thalassemic patients
nfected by hepatitis C virus in Kerman province of Iran
. Hassanshahiraviz
Faculty of medicine, rafsanjan, kerman, Iran, (Islamic
epublic of)
Background: Occult hepatitis B infection (OBI) is charac-
erized as a form of hepatitis in which despite of absence
f detectable hepatitis B surface antigen (HBsAg), HBV-DNA
s present in patient’s peripheral blood. This project was
imed to investigate the prevalence and clinical impact of
ccult HBV infection in thalassemic patients with chronic
CV infection.
Methods: In this cross-sectional study we have totally
xamined 60 patients suffering HBV and HCV infections by
CR and RT-PCR methods, respectively, in Kerman province
f Iran. ELISA technique (RADIM, Italy) was used to detect
nti-HBc, anti-HBs and HBsAg. The serum level of liver
nzymes (SGOT, SGPT, DB, TB and ALK) were analyzed in
he HCV infected patients (MAN, IRAN). Statistical analyses
erformed using t-test and Chi-square.
Results: We found that 27 cases (out of 60) were infected
y HCV but HBV-DNA was not seen in HCV infected patients.
ur ﬁndings also showed that none of samples were HBsAg
ositive but 9 (33%) (out of 27) HCV-RNA positive patients
ere anti-HBc positive and 11 (40.7%) were positive for
nti-HBs. We found that SGOT, SGPT, DB, TB and ALK are
bove normal in 27 (100%), 19 (70.3%), 12 (44.5%), 15 (55.5%)
nd 15 (55.5%) RNA-HCV positive patients, respectively. The
revalence of hepatitis C infection is very high in tha-
assemic patients and based on other studies our results
